Browse studies

Find your next paid study

27,270 recruiting studies available now

A Phase 1/2a Study to Assess Safety, Tolerability, and Efficacy of [212Pb]Pb-DOTAM-MAM279 in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[212Pb\]Pb-MP0712, in patients aged ≥18 years with Sm…

Large Cell Neuroendocrine CarcinomaLarge Cell Pulmonary Neuroendocrine Carcinoma of the Lung (LCNEC)Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)+4 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Molecular Partners AGNCT07278479

Phase 2

Investigating the Effect of TNX-1900 on Pain Management, Neural and Socio-Emotional Functioning in Patients Undergoing Pituitary Surgery

This study is testing whether oxytocin can help lessen pain by changing how people process emotions and social experiences. The goal is to better understand ho…

PainPituitary Surgery

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Yale UniversityNCT07730294

Observational

A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)

The purpose of this study is to test the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (a Neurostim device) on children with pain and Pos…

Post-Concussion SyndromeCOVID Long-HaulCOVID-19

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Hospital of Orange CountyNCT04978571

Phase 3

Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder

This randomized, double-blind, placebo-controlled clinical trial investigates the use of Food and Drug Administration (FDA)-approved cannabidiol (EPIDIOLEX®) a…

Generalized Anxiety Disorder (GAD)Anxiety Disorders

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Wayne State UniversityNCT07123467

Observational

Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy

The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic sa…

Sleep Apnea

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Zoll Medical CorporationNCT06556693

Phase 2

A Phase 2/3 Multicenter, Open-label, Randomized, Active-Control Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (waveLINE-003)

The purpose of this Phase 2/3, randomized, multisite, open-label, dose confirmation, and expansion study is to evaluate the safety, and efficacy of zilovertama…

DLBCLDiffuse Large B-Cell Lymphoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT05139017

Phase 1

A Randomized, Double-Blind, Placebo-Controlled, Within-Subject Crossover Trial of a Single 4 mg Dose of Nicotine Polacrilex Gum on Auditory Oddball P3, Oddball Task Performance, and Resting-State EEG in Non-Smoking Adults With Chronic Tinnitus

This study tests whether a single dose of nicotine gum changes brain responses to sounds and the ability to detect target sounds in non-smoking adults with chr…

TinnitusChronic Subjective Tinnitus

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Xianhui WangNCT07877701

Phase 4

Biometabolic Impact of Continuation of GLP-1 Agonists Following Bariatric

Glucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivity and release of insulin from the panc…

Morbid ObesityMetabolic SyndromeDiabetes Mellitus+2 more

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of Missouri-ColumbiaNCT06132477

University of North Carolina Pleural Fluid Registry

Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to fi…

Lung CancerLung InfectionBreast Cancer+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT05620329

Phase 1

A Pilot Trial of Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease

A promising approach for the treatment of genetic diseases is called gene therapy. Gene therapy is a relatively new field of medicine that uses genetic materia…

Sickle Cell DiseaseSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Daniel BauerNCT07708350

Phase 2

A Phase 2 Study of Blinatumomab in Combination With Chemotherapy for Infants With Newly Diagnosed Acute Lymphoblastic Leukemia With Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax

This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic le…

Acute Leukemia of Ambiguous LineageB Acute Lymphoblastic Leukemia

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06317662

Phase 1

A Phase 1/2a, Multi-center, Open-label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of PBGENE-DMD in Participants With Duchenne Muscular Dystrophy (FUNCTION-DMD)

The purpose of this Phase 1/2a trial is to evaluate the safety, tolerability, and preliminary efficacy of PBGENE-DMD in patients with DMD harboring mutations a…

Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Precision BioSciences, Inc.NCT07429240